25 of the Best Hematologists Near Me

Bilal Anouti is a Hematologist and an Oncologist practicing medicine in Chicago, Illinois. He has been practicing medicine for over 10 years. His clinical expertise encompasses Lung Cancer. Dr. Anouti is board certified in American Board Of Internal Medicine - Hematology (Certified). Dr. Anouti is currently accepting new patients.

Alexander Barbaro, MD, specializes in medical oncology, hematology and internal medicine, and is an assistant professor at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell.Drawing on a lifelong love of science, Dr. Barbaro first became attracted to medicine because it combined research with making a difference in people's lives. After earning his medical degree at Temple University School of Medicine, he did a residency at Montefiore Medical Center and a fellowship at NYU Langone Health. He chose oncology as a specialty because, during training, he saw and appreciated the patient-doctor relationships forged in that field.In some specialties, you may see a patient once for 15 minutes. But with oncology, you're on a journey with a patient, you're working together, he says. You have deep, meaningful relationships and that's what attracted me, along with the innovations in cancer care, which are very exciting.Dr. Barbaro joined Northwell in 2023, in part because it allowed him to expand his ability to teach. He'd been a physics tutor in college, and then received a commendation during residency for organizing lectures for medical students. That passion for education extends to patient care because it provides a level of empowerment and advocacy that's essential for oncology patients and their families, he believes.Doctors should be teachers as well as care providers, says Dr. Barbaro. I take the approach where I'm not just spitting jargon at patients, I'm helping them understand what it means to have this diagnosis and what treatment entails. It's incredibly important to me to educate patients in a way that gives them more confidence and a sense of control over their care.He's establishing a working group at Northwell focusing on patient education, especially when it comes to side effects of new cancer therapies. His goal is to stratify risks and anticipate side effects in a way that leads to minimizing them, in order to keep boosting beneficial outcomes.In terms of what patients have taught him, Dr. Barbaro says he's learned about resiliency, particularly in the midst of a difficult diagnosis. He's often inspired by the strength of his patients, as well as that of their families and friends. Almost every day, I'm impressed by the human spirit, he says. His clinical expertise encompasses Thyroid Cancer and Salivary Gland Tumors. Dr. Barbaro is board certified in American Board Of Internal Medicine/Medical Oncology, American Board Of Internal Medicine, and American Board Of Internal Medicine/Hematology. Dr. Barbaro is currently accepting new patients.

Moisey Khanimov, MD, is a highly skilled oncologist and hematologist specializing in the treatment of gastrointestinal malignancies both luminal and hepatobiliary. As an assistant professor at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Dr. Khanimov is dedicated to providing cutting-edge and compassionate care to his patients.Dr. Khanimov completed his medical degree at SUNY Upstate Medical University College of Medicine and went on to complete his residency and chief residency in Internal Medicine at North Shore-Long Island Jewish Health System. He furthered his expertise with a fellowship specializing in Hematology/Oncology at Montefiore Medical Center - Moses Division.With a particular interest in luminal and hepatobiliary cancers, Dr. Khanimov has spent the second half of his fellowship exclusively dedicated to treating patients with gastrointestinal malignancies. He is committed to staying at the forefront of his field and utilizes the latest advancements and evidence-based practices in cancer treatment.Dr. Khanimov sees patients at the Northwell Health Cancer Institute in Rego Park, where he provides personalized and comprehensive care to individuals facing a cancer diagnosis. He is board-certified in Internal Medicine, Hematology, and Oncology by the American Board of Internal Medicine.In addition to his clinical practice, Dr. Khanimov holds an academic title as Assistant Professor at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. He is passionate about education and mentorship, actively participating in the training of future physicians.With his extensive knowledge and compassionate approach, Dr. Moisey Khanimov is dedicated to delivering outstanding care and helping patients on their journey to recovery. His clinical expertise encompasses Colorectal Cancer, Esophageal Cancer, Stomach Cancer, and Intestinal Cancer. Dr. Khanimov is board certified in American Board Of Internal Medicine/Medical Oncology, American Board Of Internal Medicine, and American Board Of Internal Medicine/Hematology. Dr. Khanimov is currently accepting new patients.

Alice Lee, MD, is Director, Early Phase Clinical Trials program and Director, Pediatric Sarcoma program at the Children’s Hospital at Montefiore Einstein and Assistant Professor, Pediatrics at our Albert Einstein College of Medicine. Dr. Lee’s clinical focus is on the treatment of children and young adults with sarcomas. She also has special interest in novel treatments for children with relapsed or refractory cancers. Her clinical expertise encompasses Immune Thrombocytopenic Purpura (ITP). Dr. Lee is currently accepting new patients.

Pankaj Gupta is a Hematologist practicing medicine in Long Beach, California. Dr. Gupta is currently accepting new patients.

Paige Ganem is a Hematologist Oncology provider practicing medicine in Greenville, South Carolina. Dr. Ganem is board certified in American Board Of Internal Medicine. Dr. Ganem is currently accepting new patients.

As a member of the Duke Cancer Network, my goal is to provide top notch care for all my patients close to home. The collaboration with Duke provides our patients access to cutting edge research and clinical trials. I treat all types of cancers and many blood related disorders. I believe in patient centered care where my role is to explain diagnosis and treatment options in a way they can understand and are able to make decisions. Other than medicine, I love spending time with my family, cooking, and gardening. Dr. Vishnuvardhan is board certified in American Board Of Internal Med, Medical Oncology , American Board Of Internal Med, Hematology, and American Board Of Internal Med, Internal Medicine . Dr. Vishnuvardhan is currently accepting new patients.

Arjun Natarajan is a Hematologist and an Oncologist practicing medicine in Aurora, Illinois. Dr. Natarajan is board certified in American Board Of Internal Medicine, Medical Oncology. Dr. Natarajan is currently accepting new patients.

Geraldine O'Sullivan Coyne, MD, PhD, MRCPI, is the system head of Northwell and director of clinical research at New York State's first START Center for Cancer Research site, located at the R.J. Zuckerberg Cancer Center at Long Island Jewish Medical Center. START is a global network of sites focused on bringing early-phase oncology trials to community-based centers.She joins Northwell Health after two years as a clinical investigator at START Dublin in Ireland. Prior to that, Dr. O'Sullivan spent 10 years at the National Cancer Institute in Bethesda, Maryland, where she completed fellowships in hematology/oncology and advanced developmental therapeutics, and held leadership roles including staff clinician in the Developmental Therapeutics Clinic (DTC) and Early Clinical Trials Development Program.Dr. O'Sullivan received her medical training at the Royal College of Physicians of Ireland and earned a PhD in molecular medicine from University College Cork School of Medicine's Cork Cancer Research Center. Her years of education and experience have generated more than 100 published research works, numerous clinical awards and international recognition and respect.Her aim now is to partner the expertise and resources of Northwell with START to bring cutting-edge early-stage oncology trials to Long Island. Traditionally, clinical trials have been predominantly run at large academic centers. Unless you live nearby, you have to leave your local system and potentially travel a great distance to participate. Now, FDA-regulated trials will be available where our patients live for a wide breadth of solid tumors and hematological malignancies, including both common and rare cancers.An additional focus for Dr. O'Sullivan is improving patient safety. In the modern era, the molecules we're working with are very strong and targeted, but just because they are at earlier stages of development doesn't mean they are unsafe or ineffective. I want patients to know how important their safety is to me, and that most of the drugs will go on to later stage trials. Interacting with patients is hands down my favorite part of this job. Their safety is my number one priority. Dr. Coyne is currently accepting new patients.

Rakesh Biswas is a Hematologist Oncology specialist and an Oncologist practicing medicine in Fairfax, Virginia. His clinical expertise encompasses Esophageal Cancer, Gallbladder Cancer, and Liver Cancer. Dr. Biswas is board certified in Internal Medicine. Dr. Biswas is currently accepting new patients.

Rohan U. Mehta, MD, is a fellowship-trained attending hematologist/oncologist with Advanced Care Oncology and Hematology (ACOHA), part of Atlantic Medical Group (AMG). He is board-certified in internal medicine, hematology & oncology by the American Board of Internal Medicine, and is trained in all malignancies and blood disorders. Dr. Mehta is committed to advancing health care and empowering patients through strong communication and personalized care, utilizing cutting-edge therapeutics and the latest data-driven advancements in cancer treatment. His approach focuses on treating the human condition as much as the disease process.After earning his medical degree at International American University College of Medicine, Dr. Mehta completed his internal medicine residency at Mercy Hospital & Medical Center in Chicago, IL, where he was named chief resident. He then completed a fellowship in hematology and medical oncology, serving as chief fellow at Jersey Shore University Medical Center in Neptune, NJ. Prior to joining ACOHA as an attending physician, he held positions as an instructor of medicine at Loyola University Medical Center/Trinity-Mercy Chicago Program and as a hospitalist in the Chicago area.An avid educator, Dr. Mehta actively contributed to the academic community through lectures, presentations, and scholarly activities. He has presented at national medical conferences and has published articles in peer-reviewed medical journals. He has been involved in various committees and initiatives, including cofounding resident wellness programs and mentorship programs aimed at supporting medical professionals in personal and professional development, as well as volunteering as a medical professional in southern Uganda for several years.Dr. Mehta is fluent in English and Gujarati, conversational in Hindi, and competent in basic Spanish. He is a member of the American Society of Hematology, the American Society of Clinical Oncology, the American College of Physicians, and the American Association of Physicians of Indian Origin. Dr. Mehta is a participating provider of the Atlantic Accountable Care Organization. Dr. Mehta is board certified in American Board Of Internal Medicine. Dr. Mehta is currently accepting new patients.

David Huang is a Hematologist and an Oncologist practicing medicine in New Hyde Park, New York. Dr. Huang is currently accepting new patients.

The Chen laboratory studies how cancer and its immune microenvironment sense and respond to stresses and therapeutic insults to evade immune surveillance and develop drug resistance. We specialize in ER stress, Unfolded Protein Response (UPR), immunology, cancer biology, biochemistry, transgenic and preclinical animal models. Our research aims to elucidate the significance and mechanisms of stress responses in therapy resistance and anti-tumor immunity, and develop mechanism-based novel therapies to overcome therapy resistance and transform cancer to a manageable chronic disease (Nat Rev Cancer, 2021). Our study published in JCI revealed a critical role of the IRE1a/XBP1 branch of the UPR in mediating chemotherapy resistance and led to the first-in-human clinical trial of IRE1a RNase inhibitor. Our efforts in understanding proteostasis regulation revealed the direct cross-talk between oncogenic signaling and the protein quality control machinery and uncovered the mechanisms that account for the proteostasis rewiring in response to KRAS inhibition, allowing the drug-resistant cells to escape oncogenic KRAS addiction and gain resistance (Science, 2023). Another research area of the Chen laboratory focuses on ER Associated Degradation (ERAD). We recently discovered the crosstalk between ERAD complex and UPR in maintaining proteostasis and niche interactions (Nat Cell Biol, 2020, eLife, 2021). Dr. Chen is board certified in Board Certification - Internal MedicineAmerican Board Of Internal MedicineBoard Certification - Hematology And Medical OncologyAmerican Board Of Internal Medicine. Dr. Chen is currently accepting new patients.

Alissa Baker, MD, is an Instructor in Pediatric Hematology/Oncology at Albert Einstein College of Medicine. Her clinical focus is in pediatric sarcomas with an interest in identifying biomarkers of metastases, as well as identifying new adjuvant therapies for this high-risk patient population. Dr. Baker joined the Montefiore team in 2018. Dr. Baker received her Doctor of Medicine from Penn State College of Medicine. She completed her residency in Pediatrics at Yale-New Haven Hospital, where she led the Quality Improvement team for the Pediatric Hematology/Oncology unit. Following residency, she completed her fellowship in Pediatric Hematology/Oncology at Johns Hopkins Hospital and The National Institutes of Health. Dr. Baker’s research focuses on Ewing sarcoma metastasis biology, with a specialized focus on Wnt signaling, using zebrafish as a model of sarcoma metastasis for high throughput drug screens to identify new agents, screening patient plasma and tissue samples for biomarkers of potential metastasis, and identifying circulating tumor cells in the blood of sarcoma patients as a possible correlative to disease burden. Her publications include a co-first author sentinel nature paper on mutation profiling in human cancer and a recent paper on the effects of Wnt signaling inhibition in Ewing sarcoma. In 2017, Dr. Baker received the Pearl M. Stetler Grant for Women Physicians. In 2018, she received the Paul Calabresi K12 Award in Clinical Oncology for her research in Ewing sarcoma biology. Dr. Baker is board certified and an active member of the American Academy of Pediatrics. In addition, she is a member of the American Association for Cancer Research and the National Pediatric Cancer Foundation. Her clinical expertise encompasses Immune Thrombocytopenic Purpura (ITP). Dr. Baker is currently accepting new patients.

Amrit Bhaskarla is a Hematologist and an Oncologist practicing medicine in Dekalb, Illinois. Dr. Bhaskarla is currently accepting new patients.

Philosophy of care | My goal is to empower patients and their families by explaining their disease and treatment options so they understand the illnesses that have affected their lives and can make informed decisions about their care and path forward. | Why I entered medicine | I find the body’s hematologic and immune systems to be awe-inspiring. I went into medicine to about how they balance infection prevention and cancer detection while minimizing the damage to healthy cells and organs. A deep understanding of how such systems work helps us anticipate the ways they malfunction and how to fix them. | Community involvement | I would like to expand the bone marrow donor registry, especially among underrepresented demographics and ethnicities. Too many people are unable to find a match or suffer from complications caused by suboptimal matches. | Personal interests | I enjoy tending my terrariums, gardening and reading (especially science fiction and fantasy novels). I also enjoy time with my family and snuggling our beautiful (but brainless) orange tabby cat. Dr. Rivera is board certified in American Board Of Internal Medicine - Hematology. Dr. Rivera is currently accepting new patients.

Tara L. Magge, MD, is a medical oncologist who specializes in the treatment of all medical oncology and hematology patients. Board-certified in internal medicine, Dr. Magge received her medical degree from Geisinger Commonwealth School of Medicine in Danville. She completed her fellowship in hematology/oncology at the University of Pittsburgh and her residency in internal medicine at the University of Cincinnati in Ohio. Dr. Magge is board certified in American Board Of Internal Medicine. Dr. Magge is currently accepting new patients.

Rana Douli is a Hematologist and an Oncologist practicing medicine in Rego Park, New York. Dr. Douli is board certified in American Board Of Internal Medicine/Medical Oncology, American Board Of Internal Medicine, and American Board Of Internal Medicine/Hematology. Dr. Douli is currently accepting new patients.

William Flood, MD, specializes in hematology oncology and is board-certified in medical oncology by the American Board of Internal Medicine. He practices at UPMC Hillman Cancer Center in Coudersport and Williamsport. Dr. Flood received his medical degree from Temple University Lewis Katz School of Medicine and completed his residency at Duke School of Medicine, followed by a fellowship at The Johns Hopkins University School of Medicine. Dr. Flood is board certified in American Board Of Internal Medicine. Dr. Flood is currently accepting new patients.

Richard Foulke is a Hematologist practicing medicine in Charlotte, North Carolina. Dr. Foulke is board certified in Hematology. Dr. Foulke is currently accepting new patients.

Dr. Rachel Levy is a hematologist and oncologist who treats patients with blood disorders, hematologic malignancies, and solid tumors. Dr. Levy is board certified in American Board Of Internal Medicine. Dr. Levy is currently accepting new patients.

Lauren Botero, MD, is a physician specializing in hematology and oncology with Atlantic Medical Group (AMG). Board-certified in hematology and internal medicine by the American Board of Internal Medicine, she treats patients with various cancers and blood disorders. Dr. Botero is dedicated to providing compassionate, personalized care to all patients and ensuring they are educated about their condition and treatment.After Dr. Botero obtained her BS in Neurobiology and Physiology, Biology from University Maryland, College Park, MD, she earned her medical degree from Jefferson-Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA. She then performed an internal medicine residency at Memorial Sloan Kettering Cancer Center and Mount Sinai West-Morningside, followed by a hematology and oncology fellowship at Montefiore Einstein Comprehensive Cancer Center, New York, NY. She has authored multiple peer-reviewed publications, delivered numerous national and international presentations, and is a participating provider of the Atlantic Accountable Care Organization. Dr. Botero is currently accepting new patients.

Dr. Vianna is a classical and malignant hematologist and associate physician in the Division of Hematology of the Brigham and Women’s Hospital (BWH)/ Dana Farber Cancer Institute (DFCI). He is a Clinical Instructor at Harvard Medical School, Boston, MA and an active member of the Amyloidosis Program at BWH/DFCI. Dr. Vianna was born in Belo Horizonte Brazil. He earned his undergraduate degree at Vanderbilt University in molecular and cellular biology and MD degree from University of Central Florida under an institutional scholarship. He completed his Internal Medicine residency at Stanford University in Palo Alto, CA and hematology-oncology fellowship at Columbia University/ New York Presbyterian Hospital in New York, NY. Dr Vianna attends to the care of patients with AL amyloidosis, multiple myeloma, MGUS, smoldering myeloma as well as benign and other malignant hematological conditions at DFCI and BWH. His clinical and research focus is on immunoglobulin light chain (AL) amyloidosis and he holds a special interest in hematology medical education. Dr. Vianna is the recipient of numerous teaching and research awards, including the American Society of Hematology (ASH) Research Training Award for Fellows and is a member of the ASH Medical Educators Institute. Dr. Vianna is board certified in Hematology and Internal Medicine. Dr. Vianna is currently accepting new patients.

Dr. Foxworthy is a hematologist-oncologist in the Johns Hopkins All Children’s Cancer and Blood Disorders Institute. She joined the hospital staff in 2024. She sees patients at the hospital’s main campus in St. Petersburg, Florida, and at Outpatient Care, Tampa. She earned her medical degree from Mercer University School of Medicine in Macon, Georgia. She completed her internship and residency in pediatrics at University of Alabama at Birmingham, followed by a fellowship in pediatric hematology-oncology at University of Alabama at Birmingham. She also earned her Master of Science in Public Health with a concentration in outcomes research from University of Alabama at Birmingham School of Public Health. Her clinical expertise encompasses Immune Thrombocytopenic Purpura (ITP). Dr. Foxworthy is board certified in American Board Of Pediatrics. Dr. Foxworthy is currently accepting new patients.

Jesse Drapekin is a Hematologist Oncology specialist and an Oncologist practicing medicine in Boardman, Ohio. Dr. Drapekin is board certified in American Board Of Internal Medicine. Dr. Drapekin is currently accepting new patients.